US2020102345A1PendingUtilityA1
Ligand functionalized polymers
Est. expiryMar 3, 2030(~3.6 yrs left)· nominal 20-yr term from priority
Inventors:Jerald K. RasmussenKannan SeshadriRobert T. Fitzimons, Jr.James I. HembreCatherine A. BothofErin A. SatterwhiteGeorge W. GriesgraberYi HeLouis C. Haddad
G01N 33/545Y10T442/20C08L 83/08Y10T428/2998Y10T428/249991G01N 33/54393C12Q 1/04C08G 73/0206C07K 1/14C08L 79/02C08G 73/022C08G 73/028C08F 120/60Y10T428/249978C08L 77/04Y10T428/2935C08G 69/10C12N 7/02B01D 21/01C08F 126/02C12N 11/08C12N 11/091C12N 11/082
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.
Claims
exact text as granted — not AI-modified1 .- 23 . (canceled)
24 . A complex comprising:
a) a water soluble or water-dispersible aminopolymer functionalized with pendent or catenary guanidinyl groups; and b) a neutral or negatively charged target biological species derived from a cell culture or fermentation process.
25 . The complex of claim 24 , wherein the aminopolymer functionalized with pendent or catenary guanidinyl groups is of the formula:
wherein
R 2 is a H, C 1 -C 12 alkyl, C 5 -C 12 (hetero)aryl, or a residue of the polymer chain;
each R 3 is independently H, C 1 -C 12 alkyl, or C 5 -C 12 (hetero)aryl,
each R 4 is H, C 1 -C 12 alkyl or alkylene, C 5 -C 12 (hetero)aryl or (hetero)arylene, cyano, or —C(═NH)—N(R 2 )-Polymer,
Polymer is the aminopolymer chain; and
n is 1 or 2.
26 . The complex of claim 24 , wherein said biomacromolecules are selected from proteins, enzymes, nucleic acids, and endotoxins.
27 . The complex of claim 24 , wherein said biological species is selected from bacteria, viruses, cells, cell debris, and spores.
28 . The complex of claim 24 , wherein the amino polymer is selected from the group consisting of polyethylenimine, polylysine, polyaminoamides, polyallylamine, polyvinylamine, polydimethylamine-epichlorohydrin-ethylenediamine, polyaminosiloxanes and dendrimers formed from polyamidoamine (PAMAM) and polypropylenimine.
29 . The complex of claim 24 , wherein 0.1 to 100 mole percent of the available amino groups of the aminopolymer are functionalized with guanidinyl groups.
30 . The complex of claim 24 , wherein the guanidinyl groups of the functionalized aminopolymer are pendent from the polymer chain.
31 . The complex of claim 24 , wherein guanidinyl groups of the functionalized aminopolymer are in the aminopolymer chain.
32 . The complex of claim 27 , wherein the cells are selected from archaea, bacteria, and eucaryota.
33 . The complex of claim 24 , wherein the amount of ligand-functionalized polymer relative to the amount of target biological species is 0.01% to 100% by weight.
34 . The complex of claim 24 , wherein a portion of the amino groups of the ligand-functionalized polymer further comprise alkyl or acyl groups.
35 . The complex of claim 24 , wherein the functionalized aminopolymer is crosslinked.
36 . The complex of claim 24 , wherein the functionalized aminopolymer is uncrosslinked.
37 . A method of separating a target biological species from a fluid comprising the target biological species comprising:
a. contacting the fluid with a suspension or solution of water-soluble or water-dispersible aminopolymer functionalized with pendent or catenary guanidinyl groups represented by the following general formula:
wherein
R 2 is H, C 1 -C 12 alkyl, C 5 -C 12 (hetero)aryl, or a residue of the polymer chain;
each R 3 is independently H, C 1 -C 12 alkyl, or C 5 -C 12 (hetero)aryl,
each R 4 is H, C 1 -C 12 alkyl or alkylene, C 5 -C 12 (hetero)aryl or (hetero)arylene, cyano, or —C(═NH)—N(R 2 )-Polymer,
n is 1 or 2; and
“Polymer-N(R 2 )—” is the linkage formed between an amine group of the polyamino polymer and guanylating agent;
b. forming a complex in the fluid that comprises the aminopolymer functionalized with guanidinyl groups and the target biological species; and
c. separating the complex from the fluid;
wherein the target biological species is selected from biomacromolecules and microbiological species and wherein the fluid is a cell culture or fermentation broth.Join the waitlist — get patent alerts
Track US2020102345A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.